Heart valve disease treatment ranges from regular monitoring and medication to surgical repair or replacement, depending on how severe the condition is and how much it affects your daily life. Many people with mild valve disease need no intervention at all, while those with moderate to severe disease have more options today than ever before, including several procedures that don’t require open-heart surgery.
When Treatment Isn’t Needed Yet
Not every valve problem requires immediate action. If your valve disease is mild and you have no symptoms, your doctor will likely recommend a “watchful waiting” approach: regular checkups and echocardiograms to track whether the condition is progressing. This can go on for years. Many people with mild valve disease never need surgery.
During this monitoring phase, you may be prescribed medications to manage symptoms or protect your heart. These don’t fix the valve itself but can reduce the workload on your heart while your condition is being tracked. Common options include drugs that lower blood pressure, control heart rate, or reduce fluid buildup. If you’re at risk for blood clots, particularly with certain valve conditions or irregular heart rhythms, blood thinners may be added.
Valve Repair vs. Replacement
When valve disease progresses to the point where it’s causing symptoms or threatening heart function, the core decision is whether to repair the existing valve or replace it entirely. Repair is generally preferred when it’s feasible because it preserves your own tissue and typically means fewer complications long term. But not all valves can be repaired. The mitral valve, which sits between the left chambers of your heart, is the one most commonly repaired. Aortic valves are almost always replaced rather than repaired.
For replacement, there are two main types of artificial valves. Mechanical valves are extremely durable and can last a lifetime, but they require you to take blood-thinning medication (warfarin) for the rest of your life to prevent clots from forming on the valve. Tissue valves, made from animal tissue, don’t require lifelong blood thinners but have a limited lifespan. Age is the biggest factor in how long a tissue valve lasts: they rarely fail in people over 70 but almost always fail in people under 50. That tradeoff between durability and the burden of lifelong blood thinners is one of the most important conversations you’ll have with your care team.
Open-Heart Surgery
Traditional open-heart surgery remains the gold standard for many valve conditions, particularly in younger patients and those with complex anatomy. The surgeon accesses the heart through the breastbone, stops the heart temporarily using a heart-lung machine, and either repairs or replaces the damaged valve. For mitral valve repair, this often involves reshaping the valve opening with a supportive ring (called an annuloplasty ring) or reattaching torn support structures.
Minimally invasive versions of these surgeries are increasingly common. Instead of splitting the full breastbone, surgeons can work through a small incision between the ribs. The procedure itself is similar, but the smaller opening generally means less pain and a faster recovery.
Catheter-Based Procedures
The biggest shift in valve treatment over the past two decades has been the rise of catheter-based (transcatheter) procedures, which avoid open-heart surgery altogether. A thin tube is threaded through a blood vessel, usually in the groin, and guided to the heart to repair or replace a valve.
For aortic valve disease, transcatheter aortic valve replacement (often called TAVR or TAVI) has evolved from a last resort for patients too sick for surgery into the primary treatment for most people with severe aortic stenosis. Clinical trials comparing TAVR to open-heart surgery in low-risk patients found the outcomes were comparable. European guidelines now recommend TAVR for patients 75 and older regardless of surgical risk, since the less invasive approach offers a smoother recovery with similar results. The procedure is typically done through the femoral artery in the leg, which maximizes the benefit over traditional surgery.
One important caveat: people born with a bicuspid aortic valve (two flaps instead of the usual three) may not be ideal candidates for TAVR. Trial data showed notably higher rates of complications with TAVR in these patients compared to open surgery, so surgical replacement is still preferred for most of them.
For the mitral valve, a technique called transcatheter edge-to-edge repair (TEER) has become the leading catheter-based option. A small clip device is guided to the leaking valve and used to pinch the two valve flaps together at the point where blood is leaking backward. This reduces the leak without open surgery. It’s approved for patients with significant mitral regurgitation who are considered high risk for traditional surgery.
For the tricuspid valve, on the right side of the heart, catheter-based options have lagged behind but are catching up. A recent international trial published in the New England Journal of Medicine found that transcatheter tricuspid valve replacement was superior to medication alone in patients with severe tricuspid regurgitation. The improvement was driven primarily by better symptoms and quality of life, though the procedure carried higher rates of serious bleeding (15.4% vs. 5.3%) and a greater need for a permanent pacemaker afterward (17.4% vs. 2.3%).
How Doctors Decide Which Approach to Use
The choice between open surgery and a catheter-based procedure depends on several factors beyond just the valve itself. Your age, overall health, the specific anatomy of your valve, and your surgical risk all play a role. Surgical risk is formally calculated using scoring systems that factor in coexisting conditions to estimate the chance of dying within 30 days of surgery. A score below 4% is considered low risk, 4 to 8% is intermediate, and above 8% is high risk.
Younger patients with low surgical risk are more likely to be recommended for open surgery, especially if they need a mechanical valve that could last their entire life. Older patients or those with significant health problems increasingly receive catheter-based procedures, which involve shorter hospital stays and faster recoveries. Anatomical factors matter too: heavy calcium buildup on the aorta can make surgery more dangerous by increasing the risk during clamping, which may tip the decision toward a catheter-based approach. Conversely, unusual valve anatomy or severe calcium deposits near the valve opening can make catheter procedures riskier.
Recovery After Valve Surgery
After open-heart valve surgery, you can expect to stay in the hospital for five to seven days. Full recovery takes about four to eight weeks, though most people feel noticeably tired for the first three weeks. You’ll be told to avoid lifting anything heavier than 15 pounds for the first six to eight weeks while your breastbone heals. Most people return to work somewhere between six and twelve weeks after surgery.
Recovery from catheter-based procedures is substantially shorter. Because there’s no chest incision, many patients go home within one to three days and return to normal activities much sooner. This shorter recovery is one of the main reasons catheter-based approaches have become so popular, particularly for older adults who may struggle with a long surgical recovery.
Regardless of the approach, follow-up care is ongoing. If you received a mechanical valve, you’ll need regular blood tests to make sure your blood-thinning medication is at the right level. If you received a tissue valve, your doctor will monitor it over the years for signs of deterioration, since you may eventually need a second procedure. And if your valve was repaired rather than replaced, periodic imaging will confirm the repair is holding up.